TMCnet News

Lowest Beta in the Biotechnology Industry Detected in Shares of Poniard Pharmaceuticals (PARD, ROSG, RGEN, NNVC, QLTI)
[January 06, 2013]

Lowest Beta in the Biotechnology Industry Detected in Shares of Poniard Pharmaceuticals (PARD, ROSG, RGEN, NNVC, QLTI)


Jan 06, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the lowest betas. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and offer more stable returns.Poniard Pharmaceuticals ranks lowest with a a beta of 0.3. Following is Rosetta Genomics with a a beta of 0.3. Repligen ranks third lowest with a a beta of 0.6.



NanoViricides follows with a a beta of 0.6, and QLT rounds out the bottom five with a a beta of 0.6.

SmarTrend is tracking the current trend status for QLT and will alert subscribers who have QLTI in their portfolio or watchlist when shares have changed trend direction.


Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To TMCnet.com's Homepage ]